DOI QR코드

DOI QR Code

코로나19 후유증을 호소하는 태음인 환자에 대한 치험 1례

A Case Report of Taeeumin with Post COVID-19 Syndrome

  • 이슬 (부산대학교 한의학전문대학원) ;
  • 박지은 (부산대학교 한의학전문대학원) ;
  • 이용재 (부산대학교 한의학전문대학원 임상의학4교실 사상체질의학과) ;
  • 김소형 (도솔한방병원) ;
  • 이정윤 (부산대학교 한의학전문대학원 임상의학4교실 사상체질의학과)
  • Lee, Seul (School of Korean Medicine, Pusan National University) ;
  • Park, Jieun (School of Korean Medicine, Pusan National University) ;
  • Lee, Yong-jae (Dept. of Sasang Constitutional Medicine, Div. of Clinical Medicine 4, School of Korean Medicine, Pusan National University) ;
  • Kim, So-hyoung (Dosol Korean Medicine Hospital) ;
  • Lee, Jeongyun (Dept. of Sasang Constitutional Medicine, Div. of Clinical Medicine 4, School of Korean Medicine, Pusan National University)
  • 투고 : 2021.11.01
  • 심사 : 2021.11.17
  • 발행 : 2021.12.31

초록

Objectives The purpose of this case study was to report a patient with Post COVID-19 syndrome treated with Seunggeumjowi-tang based on Sasang Constitutional Medicine. Methods The patient was hospitalized after being diagnosed with COVID-19 and was suffering with post from COVID-19 syndrome such as fatigue and loss of appetite after discharge. The patient was diagnosed as Taeeumin and treated with Seunggeumjowi-tang. The progress was evaluated with the global assessment scale (GAS). Results and Conclusions Fatigue and anorexia were significantly improved, and other symptoms were restored as before. This case shows the possibility of Sasang Constitutional medication treatment for the sequelae of COVID-19.

키워드

참고문헌

  1. WHO (World Health Organization). 2020. Coronavirus Disease (COVID-19) Pandemic; 2020 Jun 1 [cited 2020 July 1]. Available from: URL: http://www.who.int/emergencies/diseases/novelcoronavirus-2019.
  2. Kim DS , Park SJ, Song MD , Chu HM, Kim KH, Choi GH et al. Telemedicine Center of Korean Medicine for treating patients with COVID-19: a retrospective analysis. Integrative Medicine Research, 2020;9(3):1-5. DOI : 10.1016/j.imr.2020.100492 (Korean)
  3. Angelo C, Roberto B, Francesco L. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603-5. DOI : 10.1001/jama.2020.12603
  4. Sandra LL, Talia WO, Carol P, Rosalinda S, Paulina A R, Angelica C, et al. More than 50 Long-term effects of COVID-19: a systematic review and meta-analysis. MedRxiv [online] 2021 [Posted January 30]. DOI : https://doi.org/10.1101/2021.01.27.21250617
  5. Ani N, Kartik S, Aakriti G, Mahesh V. M, Claire McG, Jacob S.S, et al. Post-acute COVID-19 syndrome. Nature medicine. 2021;27:601-615. https://doi.org/10.1038/s41591-021-01283-z
  6. Yim YY, Nan SH, Yeo YG, Wang CJ. Analysis on the Therapy of COVID-19 in Guangdong Province Based on the Pattern Differentiation System of Integrated Weifen, Qifen, Yingfen and Xuefen and Visceral Organs. World Science and Technology-Modernization of Traditional Chinese Medicine. 2020;23(2):1-516. DOI :10.11842/wst.20200312009
  7. Lee KE, Jeong SH, Jeong MJ, Choi YM, Song MD, Jang IS, Review on Herbal Medicine Treatment for Late Complications of COVID-19 Patients. J. Int. Korean Med. 2021;42(1):53-66. DOI :http:/dx.doi.org/10.246/jikm.2021.42.1.53 (Korean)
  8. Lee BJ, Lee JA, Kim KI, Choi JY, Jung HJ. A consensus guideline of herbal medicine for coronavirus disease 2019. Integrative Medicine Research. 2020;9(3):1-4. DOI : 10.1016/j.imr.2020.100470 (Korean)
  9. Huang CL, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020;395(10223):497-506. DOI : 10.1016/S0140-6736(20)30183-5
  10. He Ll, Gong PY, Feng Y, Zou W, Wang EL, Gu J. Analysis on application of Chinese materia medica in treatment of COVID-19 by suppressing cytokine storm. Chinese Traditional and Herbal Drugs. 2020;51(6):1375-1385. DOI :10.7501/j.issn.0253-2670.2020.06.002
  11. Kim TY, Jeon SG, Jang YH, Gotina L, Won JH, Ju YH, et al. Platycodin D, a natural component of Platycodon grandiflorum, prevents both lysosome- and TMPRSS2-driven SARS-CoV-2 infection by hindering membrane fusion. Experimental & Molecular Medicine. 2021;53(5):956-972. DOI : http://dx.doi.org/10.1038/s12276-021-00624-9
  12. Huang J, Tao G, Liu J, Cai J, Hang Z, Chen JX. Curent Prevention of COVID-19: Natural Products and Herbal Medicine. Frontiers in Pharmacology. 2020;11:58508. DOI : 10.389/fphar.2020.58508.
  13. Tripathi MK, Singh P, Sharma S, Singh TP, Ethayathul la AS, Kaur P. Identification of bioactive molecule from Withania somnifera (Ashwagandha) as SARS-CoV-2 main protease inhibitor. Journal of Biomolecular Structure and Dynamics. 2020:1-14. DOI : 10.1080/0739102.2020.1790425
  14. Kwon SW, Lee WH, Jin C, Jang IS, Jung WS, Moon SK, et al. Could herbal medicine (Soshihotang) be a new treatment option for COVID-19?: a narrative review. Integrative medicine research. 2020;9(3):1-7. DOI : 10.1016/j.imr.2020.100480
  15. Kwon SW, Chung HB, Kang YG, Jang IS, Choi JY, Jung IC, et al. The role of Korean Medicine in the post-COVID-19 era: an online panel discussion part 1 - Clinical research. Integrative medicine research. 2020;9(3):1-6. DOI : 10.1016/j.imr.2020.100478
  16. Kim HS, Kim IH. A Study on 「Dongyi Suse Bowon」 Taeumin Onbyung (Epidemic febrile disease) compared with Chinese Febrile Medicine. J Sansang Constitut Med. 2003;15(3):33-61. (Koean)
  17. Sin SW, Lee JW, Hwang MW, Lee JH, Koh BH, Lee EJ. Modification Principle of Taeeumjowi-tang in Sasang Medicine. J Sansang Constitut Med. 2016;28(3):215-224. DOI : https://doi.org/10.7730/JSCM.2016.28.3.215 (Korean)